title: Change of synaptic membrane lipid composition and fluidity by chronic administration of lithium.
abstract: The effect of chronic administration of lithium salts on the lipid composition and physical properties of the synaptosomal plasma membrane was examined in rat brain. The effect of lithium treatment has been studied on the fluorescence polarization of synaptosomal plasma membrane and artificial lipid vesicles and on the lipid composition of the membranes. Fluorescence polarization of lipophilic probes was used to study membrane lipid structure. Steady-state polarization of 1,6-diphenyl-1,3,5-hexatriene (DPH), a probe of the hydrophobic core, was significantly lower in plasma membranes from lithium-treated animals. Altered DPH polarization was due to a decrease in the order parameter of the probe. The lithium-treatment also changed the fluorescence of 1-anilino-8-naphthalene sulfonate (ANS), a probe that binds to the polar head group of the phospholipids and to proteins on the membrane surface. Synaptic plasma membranes from treated rats presented no significant changes on the cholesterol-to-phospholipid ratio, although the phospholipid class distribution was altered and the membrane phospholipid unsaturation increased. In summary, the neural plasma membranes became disorder after chronic lithium administration at therapeutic levels. This structural change may be due to changes in plasma membrane phospholipid distribution and to the degree of unsaturation of phospholipid fatty acids.
authors.affiliation: Departamento de Biologia Molecular, Facultad de Ciencias, Universidad Autónoma de Madrid, Spain.
authors.forename: B
authors.initials: B
authors.lastname: López-Corcuera
authors.forename: C
authors.initials: C
authors.lastname: Giménez
authors.forename: C
authors.initials: C
authors.lastname: Aragón
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism; D002458:Cell Fractionation; D002712:Chlorides / Q000494:pharmacology*; D002784:Cholesterol / Q000378:metabolism*; D002788:Cholesterol Esters / Q000378:metabolism; D004161:Diphenylhexatriene; D008094:Lithium / Q000494:pharmacology*; D018021:Lithium Chloride; D008297:Male; D008560:Membrane Fluidity / Q000187:drug effects*; D008563:Membrane Lipids / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D013050:Spectrometry, Fluorescence; D013570:Synaptic Membranes / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D013574:Synaptosomes / Q000378:metabolism / Q000648:ultrastructure; D013816:Thermodynamics
chemical_list: D002712:Chlorides; D002788:Cholesterol Esters; D008563:Membrane Lipids; D010743:Phospholipids; D004161:Diphenylhexatriene; D002784:Cholesterol; D008094:Lithium; D018021:Lithium Chloride